101.38 1.28 (1.28%)

35.83% Fall from 52W High

1.9M XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Analyst Upgrade
Needham upgrades Neurocrine Bio to 'Buy'; cites positive physician survey of its drug, 'Crenessity' See details